Evaluating eligibility criteria of oncology trials using real-world data and AI
Source check: Needs source check. Not independent scientific confirmation.
Finding: Emulating completed NSCLC trials on 61,094 patients showed many common exclusion criteria had minimal effect on hazard ratios; data-driven broadening more than doubled eligible patients on average and lowered hazard ratio by about 0.05.
Technology: Trial Pathfinder data-driven computational framework on real-world EHR data
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Data-driven algorithm selected criteria to broaden.
- Test and result
- Retrospective emulation of completed trials.
- Limitation / still unknown
- Observational real-world data; not a prospective trial.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/search?query=DOI:10.1038/s41586-021-03430-5
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 17 Nov 2026. Review scope: Europe PMC metadata and abstract only; Methods not read..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.